JP2014510093A5 - - Google Patents

Download PDF

Info

Publication number
JP2014510093A5
JP2014510093A5 JP2014500473A JP2014500473A JP2014510093A5 JP 2014510093 A5 JP2014510093 A5 JP 2014510093A5 JP 2014500473 A JP2014500473 A JP 2014500473A JP 2014500473 A JP2014500473 A JP 2014500473A JP 2014510093 A5 JP2014510093 A5 JP 2014510093A5
Authority
JP
Japan
Prior art keywords
stress
cell
protein complex
stress protein
inducing stimuli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014500473A
Other languages
English (en)
Japanese (ja)
Other versions
JP6009532B2 (ja
JP2014510093A (ja
Filing date
Publication date
Priority claimed from GBGB1104897.2A external-priority patent/GB201104897D0/en
Application filed filed Critical
Publication of JP2014510093A publication Critical patent/JP2014510093A/ja
Publication of JP2014510093A5 publication Critical patent/JP2014510093A5/ja
Application granted granted Critical
Publication of JP6009532B2 publication Critical patent/JP6009532B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014500473A 2011-03-23 2012-03-23 タンパク質複合体及び該タンパク質複合体を含むワクチン組成物の生産方法 Active JP6009532B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1104897.2A GB201104897D0 (en) 2011-03-23 2011-03-23 Method for the production of protein complexes and vaccine compositions comprising the same
GB1104897.2 2011-03-23
PCT/GB2012/050650 WO2012127248A1 (en) 2011-03-23 2012-03-23 Method for the production of protein complexes and vaccine compositions comprising the same

Publications (3)

Publication Number Publication Date
JP2014510093A JP2014510093A (ja) 2014-04-24
JP2014510093A5 true JP2014510093A5 (enExample) 2015-05-07
JP6009532B2 JP6009532B2 (ja) 2016-10-19

Family

ID=44013038

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014500473A Active JP6009532B2 (ja) 2011-03-23 2012-03-23 タンパク質複合体及び該タンパク質複合体を含むワクチン組成物の生産方法

Country Status (9)

Country Link
US (2) US10240179B2 (enExample)
EP (1) EP2688589B1 (enExample)
JP (1) JP6009532B2 (enExample)
CN (1) CN103458923A (enExample)
AU (2) AU2012232878A1 (enExample)
BR (1) BR112013024229A2 (enExample)
CA (1) CA2829678C (enExample)
GB (1) GB201104897D0 (enExample)
WO (1) WO2012127248A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007285775B2 (en) * 2006-08-17 2011-03-03 Sanofi Pasteur Ltd. Immunogenic PcpA polypeptides and uses thereof
GB201104897D0 (en) * 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
EP3896152A1 (en) * 2012-03-22 2021-10-20 Avita Medical Ltd Cell suspension and use thereof
CN108379553A (zh) * 2018-05-28 2018-08-10 上海市第人民医院 热休克蛋白20在氧化应激损伤疾病中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE175443T1 (de) * 1991-06-03 1999-01-15 Arch Dev Corp Verfahren und zusammensetzungen des genetischen stressantwortsystems
US5961979A (en) 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
GB9818133D0 (en) * 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine
US6495360B1 (en) 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
GB9919734D0 (en) * 1999-08-19 1999-10-20 Colaco Camilo Vaccines from infectious agents
GB9919733D0 (en) 1999-08-19 1999-10-20 Colaco Camilo Vaccines against intracellular pathogens
WO2001026432A1 (fr) 1999-10-01 2001-04-12 Seiko Epson Corporation Plaquette imprimee, dispositif a semi-conducteur et son procede de fabrication, ses essais et sa mise en boitier, et circuit integre et equipement electronique
GB0004547D0 (en) 2000-02-23 2000-04-19 Immunobiology Ltd Screening method for novel vaccine candidates and compositions obtained thereby
GB0021757D0 (en) 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
WO2002028407A1 (en) 2000-09-29 2002-04-11 University Of Connecticut Health Center Methods of recovering heat shock proteins and complexes thereof
WO2009148608A1 (en) * 2008-06-03 2009-12-10 Bin Zhang Screening methods for heat-shock response modulators
GB0816242D0 (en) 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) * 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same

Similar Documents

Publication Publication Date Title
McLaughlin et al. Propionibacterium acnes and acne vulgaris: new insights from the integration of population genetic, multi-omic, biochemical and host-microbe studies
Leung et al. Modulation of potential respiratory pathogens by pH1N1 viral infection
Ye et al. Identification and molecular typing of Streptococcus agalactiae isolated from pond-cultured tilapia in China
Baddal et al. Dual RNA-seq of nontypeable Haemophilus influenzae and host cell transcriptomes reveals novel insights into host-pathogen cross talk
BR112013031262A2 (pt) "exotoxinas a de pseudomonas com menos epítopos imunogênicos de célula b e t, e seu uso no tratamento e prevenção de câncer, bem como molécula quimérica, ácido nucleico, vetor de expressão, células, composição farmacêutica e métodos para inibir crescimento de célula-alvo e de produção de endotoxinas a de pseudomonas e de molécula quimérica".
Szczuka et al. Biofilm density and detection of biofilm-producing genes in methicillin-resistant Staphylococcus aureus strains
DK1945762T3 (da) Rationelt konstruerede meganucleaser med ændret sekvensspecificitet og DNA-bindingsaffinitet
JP2012000112A5 (enExample)
MX2021000210A (es) Metodos y productos para transfeccion de celulas.
Bibova et al. Transcriptional profiling of Bordetella pertussis reveals requirement of RNA chaperone Hfq for Type III secretion system functionality
JP2014510093A5 (enExample)
Klein et al. Occurrence and significance of pathogenicity and fitness islands in environmental vibrios
JP2014532438A5 (enExample)
HRP20201021T1 (hr) Modificirane stanice domaćini i njihova upotreba
Hernaiz et al. Epigenetic changes in prion and prion-like neurodegenerative diseases: Recent advances, potential as biomarkers, and future perspectives
JP2013531491A5 (enExample)
Budnick et al. Complete genome sequence of Klebsiella pneumoniae strain ATCC 43816
Mahboob et al. Genomic characterization and comparative genomic analysis of HS-associated Pasteurella multocida serotype B: 2 strains from Pakistan
JP2013531967A5 (enExample)
Lawrence et al. A three-way comparative genomic analysis of Mannheimia haemolytica isolates
JP2012530123A5 (enExample)
Wang et al. Exploring Mycoplasma ovipneumoniae NXNK2203 infection in sheep: insights from histopathology and whole genome sequencing
BR112014031853A2 (pt) métodos para a inativação viral e bacteriana em meios de cultura celular
Wang et al. GT transcription factors of rosa rugosa thunb. Involved in salt stress response
CN102716499B (zh) 一种海豚链球菌三价dna疫苗及其构建方法